Literature DB >> 22914861

Syk-dependent signaling pathways in neutrophils and macrophages are indispensable in the pathogenesis of anti-collagen antibody-induced arthritis.

Naoko Ozaki1, Shinobu Suzuki, Masato Ishida, Yasuyo Harada, Kohji Tanaka, Yayoi Sato, Takeshi Kono, Masato Kubo, Daisuke Kitamura, Jeffrey Encinas, Hiromitsu Hara, Hiroki Yoshida.   

Abstract

Spleen tyrosine kinase (Syk) is associated with Fcγ receptors (FcγRs) and transmits activation signals through FcγRs in myeloid cells. Thus, application of drugs to inhibit Syk activity can affect the development of immune diseases mediated by autoantibodies, while unexpected systemic effects by the inhibition may be concerned because Syk has multiple physiological functions. We used tamoxifen-inducible systemic conditional Syk knockout (KO) mice to evaluate the role of Syk in the pathogenesis of autoimmune arthritis and to investigate the systemic effects of Syk deletion. In a collagen antibody-induced arthritis model, Syk KO mice were almost completely protected from disease induction and showed significantly attenuated accumulation of neutrophils and macrophages in the joints. Syk-deleted macrophages showed less IL-6 and MCP-1 production upon FcγR ligation and exhibited reduced FcγR-mediated phagocytosis in vitro. Syk-deleted macrophages produce more RANTES upon FcγR ligation, indicating a Syk-independent signaling through the FcγR. We further found that both wild-type and Syk-deleted macrophages induced neutrophil chemotaxis upon FcγR ligation in vitro, and air-pouch model demonstrated that Syk-deleted neutrophils have a potential to infiltrate into local tissues in response to collagen and anti-collagen antibodies. However, Syk-deleted neutrophils exhibited greatly decreased neutrophil extracellular traps formation and FcγR-mediated phagocytosis. Our results indicated that Syk deficiency rendered mice completely unresponsive to immune activation by anti-collagen antibodies with disabling one pathway of FcγR-mediated signaling that was crucial for arthritis induction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914861     DOI: 10.1093/intimm/dxs078

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  23 in total

1.  Anti-inflammatory properties of prostaglandin E2: deletion of microsomal prostaglandin E synthase-1 exacerbates non-immune inflammatory arthritis in mice.

Authors:  Andrey Frolov; Lihua Yang; Hua Dong; Bruce D Hammock; Leslie J Crofford
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-08-30       Impact factor: 4.006

2.  Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease.

Authors:  Terence N Bukong; Arvin Iracheta-Vellve; Banishree Saha; Aditya Ambade; Abhishek Satishchandran; Benedek Gyongyosi; Patrick Lowe; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  Hepatology       Date:  2016-07-22       Impact factor: 17.425

3.  The selective SYK inhibitor P505-15 (PRT062607) inhibits B cell signaling and function in vitro and in vivo and augments the activity of fludarabine in chronic lymphocytic leukemia.

Authors:  Stephen E Spurgeon; Greg Coffey; Luke B Fletcher; Russell Burke; Jeffrey W Tyner; Brian J Druker; Andreas Betz; Francis DeGuzman; Yvonne Pak; Dale Baker; Anjali Pandey; Stanley J Hollenbach; Uma Sinha; Marc M Loriaux
Journal:  J Pharmacol Exp Ther       Date:  2012-12-07       Impact factor: 4.030

4.  Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression.

Authors:  Stephen P McAdoo; Gurjeet Bhangal; Theresa Page; H Terence Cook; Charles D Pusey; Frederick W K Tam
Journal:  Kidney Int       Date:  2015-02-25       Impact factor: 10.612

5.  Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.

Authors:  Nichola Cooper; Ivy Altomare; Mark R Thomas; Phillip L R Nicolson; Steve P Watson; Vadim Markovtsov; Leslie K Todd; Esteban Masuda; James B Bussel
Journal:  Ther Adv Hematol       Date:  2021-04-30

Review 6.  Functional roles of Syk in macrophage-mediated inflammatory responses.

Authors:  Young-Su Yi; Young-Jin Son; Chongsuk Ryou; Gi-Ho Sung; Jong-Hoon Kim; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2014-06-18       Impact factor: 4.711

7.  Depletion of STAT5 blocks TEL-SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice.

Authors:  C Sprissler; D Belenki; H Maurer; K Aumann; D Pfeifer; C Klein; T A Müller; S Kissel; J Hülsdünker; J Alexandrovski; T Brummer; H Jumaa; J Duyster; C Dierks
Journal:  Blood Cancer J       Date:  2014-08-22       Impact factor: 11.037

8.  Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN.

Authors:  Stephen P McAdoo; John Reynolds; Gurjeet Bhangal; Jennifer Smith; John P McDaid; Anisha Tanna; William D Jackson; Esteban S Masuda; H Terence Cook; Charles D Pusey; Frederick W K Tam
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

9.  Acute Kidney Injury Induced Lupus Exacerbation Through the Enhanced Neutrophil Extracellular Traps (and Apoptosis) in Fcgr2b Deficient Lupus Mice With Renal Ischemia Reperfusion Injury.

Authors:  Wilasinee Saisorn; Supichcha Saithong; Pornpimol Phuengmaung; Kanyarat Udompornpitak; Thansita Bhunyakarnjanarat; Peerapat Visitchanakun; Awirut Chareonsappakit; Prapaporn Pisitkun; Direkrit Chiewchengchol; Asada Leelahavanichkul
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

10.  The natural stilbenoid piceatannol decreases activity and accelerates apoptosis of human neutrophils: involvement of protein kinase C.

Authors:  Viera Jancinova; Tomas Perecko; Radomir Nosal; Klara Svitekova; Katarina Drabikova
Journal:  Oxid Med Cell Longev       Date:  2013-10-31       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.